Compound information
- Natural Products
- ZC1602710
- Molecular Formula
- C23H35N3O5S
- Molecular Weight
- 465.22974222 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-[4-(p-tolylsulfonyl)-1,4-diazepane-1-carbonyl]piperidine-1-carboxylate
- InChI
- InChI=1S/C23H35N3O5S/c1-18-6-8-20(9-7-18)32(29,30)26-13-5-12-24(16-17-26)21(27)19-10-14-25(15-11-19)22(28)31-23(2,3)4/h6-9,19H,5,10-17H2,1-4H3
- InChI Key
- NGSGOGHFRZPLPV-UHFFFAOYSA-N
- SMILES
- Cc1ccc(S(=O)(=O)N2CCCN(C(=O)C3CCN(C(=O)OC(C)(C)C)CC3)CC2)cc1
- Source
- ZINC000025916957
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 32 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 87.23 Å2 | LogP | 2.849 |
LogS | -3.925 | LogD | 3.361 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.062 | Pgp substrate | 0.894 |
HIA | 0.974 | F20 % | 0.989 |
F30 % | 0.858 | Caco-2 | -4.461 |
MDCK | -4.886 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.922 | PPB | 89.278 |
VD | 1.066 | Fu | 1.164 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.447 |
CYP2A6 substrate | 0.486 | CYP2B6 substrate | 0.65 |
CYP2C19 inhibitor | 0.578 | CYP2C19 substrate | 0.722 |
CYP2C8 substrate | 0.5 | CYP2C9 inhibitor | 0.236 |
CYP2C9 substrate | 0.989 | CYP2D6 inhibitor | 0.113 |
CYP2D6 substrate | 0.774 | CYP2E1 substrate | 0.419 |
CYP3A4 inhibitor | 0.699 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.217 | CL | 4.011 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.869 | Hepatotoxicity | 0.986 |
Mutagenicity | 0.471 | Rat Oral Acute Toxicity | 0.123 |
FDAMDD | 0.239 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.175 | Eye Corrosion | 0.002 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.029 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.336 | IGC50 | 3.243 |
LC50FM | -5.788 | LC50DM | -0.659 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.259 | NR-AR-LBD | 0.286 |
NR-AhR | 0.03 | NR-Aromatase | 0.095 |
NR-ER | 0.271 | NR-ER-LBD | 0.43 |
NR-PPAR-gamma | 0.093 | SR-ARE | 0.788 |
SR-ATAD5 | 0.333 | SR-HSE | 0.126 |
SR-MMP | 0.017 | SR-p53 | 0.057 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.